Amalgamated Bank’s GeneDx Holdings WGS Stock Holding History

Amalgamated Bank’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-598	Closed	-$78K	–	2799
2025 Q4	$78K	Buy	598 +155	+35%	+$21.3K	﹤0.01%	1737
2025 Q3	$48K	Hold	443	–	–	﹤0.01%	1851
2025 Q2	$41K	Hold	443	–	–	﹤0.01%	1880
2025 Q1	$39K	Buy	443 +22	+5%	+$1.91K	﹤0.01%	1852
2024 Q4	$32K	Hold	421	–	–	﹤0.01%	1966
2024 Q3	$18K	Hold	421	–	–	﹤0.01%	2180
2024 Q2	$11K	Buy	+421	New	+$7.98K	﹤0.01%	2412
2024 Q1	–	Sell	-1	Closed	–	–	2968
2023 Q4	$0	Hold	1	–	–	﹤0.01%	3000
2023 Q3	$0	Hold	1	–	–	﹤0.01%	3023
2023 Q2	$0	Sell	1 -739	-100%	-$5.85K	﹤0.01%	3131
2023 Q1	$9K	Buy	740 +133	+22%	+$1.77K	﹤0.01%	2837
2022 Q4	$5K	Hold	607	–	–	﹤0.01%	2939
2022 Q3	$18K	Hold	607	–	–	﹤0.01%	2844
2022 Q2	$25K	Buy	+607	New	+$41.2K	﹤0.01%	2801

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Amalgamated Bank's WGS Position: Q1 2026 in Review

Amalgamated Bank sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 598 shares — an estimated $78K sold.

Amalgamated Bank first reported a position in WGS in Q2 2022 and held it in 14 quarters. The position peaked at $78K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

Amalgamated Bank reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 598 GeneDx Holdings shares in Q1 2026, an estimated $78K.
Amalgamated Bank first reported a position in GeneDx Holdings in Q2 2022 and held it in 14 quarters.
Amalgamated Bank's GeneDx Holdings position peaked at $78K in Q4 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.